(Q67864961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

1 reference

T M Loeffler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

F W Weber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

T U Hausamen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

18 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

117 Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

S125-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy

18 September 2019

cites work

1 reference

12 December 2020

A simple quantitative HPLC assay for ifosfamide in biological fluids

1 reference

12 December 2020

Infusion of ifosfamide plus mesna

1 reference

12 December 2020

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

12 December 2020

Comparative pharmacokinetics of doxorubicin and epirubicin in patients with gastrointestinal cancer

1 reference

12 December 2020

High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial

1 reference

12 December 2020

Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.

1 reference

12 December 2020

Pharmacokinetics of divided‐dose ifosfamide

1 reference

12 December 2020

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

12 December 2020

Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy

1 reference

12 December 2020

Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)

1 reference

12 December 2020

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

1 reference

12 December 2020

Reduction of ifosfamide toxicity using dose fractionation

1 reference

12 December 2020

Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01613216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1795000%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference